118 related articles for article (PubMed ID: 24337593)
41. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
[TBL] [Abstract][Full Text] [Related]
42. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
43. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
[TBL] [Abstract][Full Text] [Related]
44. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B.
Ekiz F; Yüksel O; Koçak E; Yılmaz B; Altınbaş A; Çoban S; Yüksel I; Üsküdar O; Köklü S
J Clin Lab Anal; 2011; 25(3):162-5. PubMed ID: 21567462
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of mean platelet volume and its ratio over platelet count in children with obstructive sleep apnea syndrome.
Soyalıç H; Somuk BT; Doğru S; Gürbüzler L; Göktaş G; Eyibilen A
Kulak Burun Bogaz Ihtis Derg; 2015; 25(1):16-21. PubMed ID: 25934401
[TBL] [Abstract][Full Text] [Related]
46. Routine indexes for cirrhosis and significant fibrosis detection in patients with compensated chronic hepatitis B.
Zhang ZQ; Huang LW; Chen YP; Wang P
Dig Liver Dis; 2019 Jan; 51(1):127-134. PubMed ID: 30076017
[TBL] [Abstract][Full Text] [Related]
47. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B.
Zhang YX; Wu WJ; Zhang YZ; Feng YL; Zhou XX; Pan Q
World J Gastroenterol; 2008 Dec; 14(46):7117-21. PubMed ID: 19084920
[TBL] [Abstract][Full Text] [Related]
48. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
49. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
Zhou J; Deng Y; Yan L; Zhao H; Wang G;
Int J Infect Dis; 2016 Aug; 49():94-9. PubMed ID: 27292607
[TBL] [Abstract][Full Text] [Related]
50. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
51. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
Shin WG; Park SH; Jang MK; Hahn TH; Kim JB; Lee MS; Kim DJ; Jun SY; Park CK
Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
[TBL] [Abstract][Full Text] [Related]
52. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
[TBL] [Abstract][Full Text] [Related]
53. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
[TBL] [Abstract][Full Text] [Related]
54. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
55. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B.
Lee HJ; Seo YS; Kim DJ; Kang HS; An H; Kim JH; Cheong JY; Yim HJ; Yeon JE; Lee HS; Byun KS; Cho SW; Kim DJ; Um SH; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2011 Jun; 26(6):987-95. PubMed ID: 21198828
[TBL] [Abstract][Full Text] [Related]
56. Platelets' increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis.
Wang L; Wang B; You H; Wu X; Zhou J; Ou X; Jia J
Hepatol Int; 2018 May; 12(3):237-243. PubMed ID: 29700765
[TBL] [Abstract][Full Text] [Related]
57. Elevated mean platelet volume to platelet ratio predicts advanced fibrosis in chronic hepatitis C.
Gozdas HT; Ince N
Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):524-527. PubMed ID: 31714386
[TBL] [Abstract][Full Text] [Related]
58. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
[TBL] [Abstract][Full Text] [Related]
59. Neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis and steatosis in patients with chronic hepatitis B.
Pokora Rodak A; Kiciak S; Tomasiewicz K
Ann Agric Environ Med; 2018 Dec; 25(4):690-692. PubMed ID: 30586966
[TBL] [Abstract][Full Text] [Related]
60. Serum keratin-18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus-related cirrhosis.
Cao Z; Chen L; Li J; Liu Y; Bao R; Liu K; Yan L; Ding Y; Guo Q; Xiang X; Xie J; Lin L; Xie Q; Bao S; Wang H
J Viral Hepat; 2019 Jul; 26(7):835-845. PubMed ID: 30974482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
